The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bukina O.V.

Derzhavin Tambov State University;
Clinic «Doctor Profi»

Treatment of Reticular Veins with a Long-pulsed 1064 nm Nd:YAG Laser: a Pilot Study

Authors:

Bukina O.V.

More about the authors

Journal: Journal of Venous Disorders. 2025;19(2): 70‑76

Read: 939 times


To cite this article:

Bukina OV. Treatment of Reticular Veins with a Long-pulsed 1064 nm Nd:YAG Laser: a Pilot Study. Journal of Venous Disorders. 2025;19(2):70‑76. (In Russ., In Engl.)
https://doi.org/10.17116/flebo20251902170

Recommended articles:

References:

  1. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175-184.  https://doi.org/10.1016/j.annepidem.2004.05.015
  2. De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, Giannoukas A, Gohel M, de Graaf R, Hamel-Desnos C, Jawien A, Jaworucka-Kaczorowska A, Lattimer CR, Mosti G, Noppeney T, van Rijn MJ, Stansby G, Esvs Guidelines Committee, Kolh P, Bastos Goncalves F, Chakfé N, Coscas R, de Borst GJ, Dias NV, Hinchliffe RJ, Koncar IB, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, Björck M, Labropoulos N, Lurie F, Mansilha A, Nyamekye IK, Ramirez Ortega M, Ulloa JH, Urbanek T, van Rij AM, Vuylsteke ME. Editor’s Choice ‒ European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022;63:184-267.  https://doi.org/10.1016/j.ejvs.2021.12.024
  3. Rabe E, Breu FX, Cavezzi A, Coleridge Smith P, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P, Partsch B, Ramelet AA, Tessari L, Pannier F; Guideline Group. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29(6):338-354.  https://doi.org/10.1177/0268355513483280
  4. Sadick NS. Long-term results with a multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins. Dermatol Surg. 2001;27:365-369.  https://doi.org/10.1046/j.1524-4725.2001.00295.x
  5. Egorova EA, Kalinin RE, Suchkov IA. Complications after Laser Treatment. Journal of Venous Disorders. 2024;18(4):317-327. (In Russ.). https://doi.org/10.17116/flebo202418041317
  6. Ianosi G, Ianosi S, Calbureanu-Popescu MX, Tutunaru C, Calina D, Neagoe D. Comparative study in leg telangiectasias treatment with Nd:YAG laser and sclerotherapy. Exp Ther Med. 2019;17:1106e12. https://doi.org/10.3892/etm.2018.6985
  7. Moreno-Moraga J, Smarandache A, Pascu ML, Royo J, Trelles MA. 1064 nm Nd: YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Phlebology. 2014;29:658-666.  https://doi.org/10.1177/0268355513502786
  8. Parlar B, Blazek C, Cazzaniga S, Naldi L, Kloetgen HW, Borradori L, Buettiker U. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. J Eur Acad Dermatol Venereol. 2015;29:549e54. https://doi.org/10.1111/jdv.12627
  9. Ross EV, Domankevitz Y. Laser treatment of leg veins: Physical mechanisms and theoretical considerations. Lasers Surg Med. 2005;36(2):105-116.  https://doi.org/10.1002/lsm.20141
  10. Parlette EC, Groff WF, Kinshella MJ, Domankevitz Y, O’Neill J, and Ross EV. Optimal pulse durations for the treatment of leg telangiectasias with a neodym YAG laser. Lasers Surg Med. 2006;38:98-105.  https://doi.org/10.1002/lsm.20245
  11. Bossart S, Willenberg T, Ramelet A-A, Cazzaniga S, Hunger RE, Jafari SMS. The skin hyperpigmentation index: An objective method of measuring the intensity of hyperpigmentation after sclerotherapy. Phlebology. 2020;35(10):833-835.  https://doi.org/10.1177/0268355520941359
  12. Major A, Brazzini B, Campolmi P, Bonan P, Mavilia L, Ghersetich I, Lotti T. Nd:YAG 1064 nm laser in the treatment of facial and leg telangiectasias. Journal of the European Academy of Dermatology and Venereology. 2001;15(6):559-565.  https://doi.org/10.1046/j.1468-3083.2001.00354.x
  13. Omura NE, Dover JS, Arndt KA, Kauvar AN. B. Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser. Journal of the American Academy of Dermatology. 2003;48(1):76-81.  https://doi.org/10.1067/mjd.2003.38
  14. Özden MG, Bahçivan M, Aydin F, Şentürk N, Bek Y, Cantürk T, Turanli AY. Clinical comparison of potassium-titanyl-phosphate (KTP) versus neodymium:YAG (Nd:YAG) laser treatment for lower extremity telangiectases. Journal of Dermatological Treatment. 2010;22(3):162-166.  https://doi.org/10.3109/09546631003649679
  15. Eremia S, Li CY. Treatment of leg and face veins with a cryogen spray variable pulse width 1064-nm Nd:YAG laser-a prospective study of 47 patients. J Cosmet Laser Ther. 2001;3(3):147-153.  https://doi.org/10.1080/147641701753414960
  16. Eremia S, LI C, Umar SH. A Side–by–Side Comparative Study of 1064 nm Nd. Dermatologic Surgery. 2002;28(3):224-230.  https://doi.org/10.1046/j.1524-4725.2002.01162.x
  17. Rogachefsky AS, Silapunt S, Goldberg DJ. Nd:YAG Laser (1064 nm) Irradiation for Lower Extremity Telangiectases and Small Reticular Veins: Efficacy as Measured by Vessel Color and Size. Dermatologic Surgery. 2002;28(3):220-223.  https://doi.org/10.1046/j.1524-4725.2002.01141.x
  18. Sadick NS. Laser Treatment With a 1064-nm Laser for Lower Extremity Class I-III Veins Employing Variable Spots and Pulse Width Parameters. Dermatologic Surgery. 2003;29(9):916-919. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.